| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2124808 | European Journal of Cancer | 2006 | 5 Pages |
Abstract
Combined 1p/19q loss is mainly observed in classical OD. Responses to first line temozolomide are strongly correlated to loss of 1p. Response to second line alkylating treatment is modest even in tumours with 1p/19q loss. For further improvement of outcome in OD novel treatments are needed.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Mathilde C.M. Kouwenhoven, Johan M. Kros, Pim J. French, Elize M. Biemond-ter Stege, Wilfried J. Graveland, Martin J.B. Taphoorn, Alba A. Brandes, Martin J. van den Bent,